They’ve Got Next: The 40 Under 40 - Jonathan Davis of Kirkland & Ellis

Please describe two of your most substantial, recent wins in practice.
I advised Bristol Myers Squibb on its $90 billion acquisition of Celgene Corporation, which represents the largest purchase of a pharmaceutical company in history. Two unique challenges associated with the deal included opposition to the transaction from Wellington Management and activist shareholder Starboard Value, as well as navigating a complex FTC review process. We were able to successfully defend against the shareholder opposition and structure an antitrust remedy which included one of the largest antitrust divestitures in history to enable the deal to close.

I also represented AbbVie on ...